Study wrapper · #1169
Glucagon-Like Peptide-1 Receptor Agonists and Related Incretin Therapies in Dermatology: Patient Selection and Shared Decision-Making.
Editor's note
A narrative review rather than new data, but useful as a window into how GLP-1 therapies are rippling into specialties far from diabetes care. The authors' framing is notably measured: the evidence in dermatology is still evolving, and they lean on shared decision-making rather than firm indications. The catalog of appearance-related effects, particularly facial volume loss and hair shedding, tracks closely with what the community has been reporting anecdotally.
Plain-language abstract
Dermatologists are seeing more patients on GLP-1 drugs and wrote a practical review of what that means for skin care. It covers which patients with skin conditions like psoriasis might see benefit from weight loss, and the side effects patients notice most, including facial volume loss, hair shedding, and stomach upset.